-
AI and the Prepared Mind: Engineering Luck in Drug Discovery
AI drug discovery designs perfect molecules, but 70% die in Phase 2. The gap isn’t chemistry—it’s the embodied clinical context AI can’t replicate.
-
How AI Gets Paid Is How It Scales
Healthcare AI economics depend on creating a labor dividend. AI business models must shift from billing human minutes to AI-driven outcomes.
-
When AI Meets Aggregation Theory in Healthcare
Epic isn’t a true platform by Bill Gates’s test. Healthcare aggregation theory shows how AI could build the first real demand-side platform in care.
-
America’s Patchwork of Laws Could Be AI’s Biggest Barrier in Care
50 states, 50 AI rules—healthcare AI regulation creates impossible compliance. A federal framework could separate assistive from autonomous AI agents in care.
-
The Gameboard for AI in Healthcare
Healthcare AI is stuck helping clinicians draft notes, not prescribe. Mapping the AI healthcare landscape from Level 1 copilots to Level 5 autonomy.
-
GPT-5 vs Grok4, No Health AI Champion Yet
GPT-5 and Grok4 both fail basic anatomy and physics checks on the HealthBench. AI medical benchmarks show progress, not clinical readiness.
-
AI Can’t “Cure All Diseases” Until It Beats Phase 2
AI-designed drugs move fast but 70% still fail Phase 2 clinical trials. Live-biology platforms testing on evolving patient tissue could crack the bottleneck.
-
Yippee-Ki-Yay, Paper Clipboard
The paper clipboard could finally die. Digital health identity, insurance cards, and FHIR summaries are the rails for EHR modernization—if 60+ partners ship.
-
Health Privacy in the AI Era
No law grants AI chats physician-patient privilege. Courts can compel your health data from ChatGPT. Why AI HIPAA gaps leave patients exposed.
-
Level‑5 Healthcare: Why Prescribing Will Decide When AI Becomes a Real Doctor
AI aces medical exams but won’t write prescriptions. Autonomous AI healthcare starts with simple refills and titrations—FDA already approved insulin loops.